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Abstract
Obesity is a growing problem in developed countries, 
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and surgery is the most effective treatment in terms of 
weight loss and improving medical comorbidity in a high 
proportion of obese patients. Despite the advances in 
surgical techniques, some patients still develop acute 
and late postoperative complications, and an endoscopic 
evaluation is often required for diagnosis. Moreover, 
the high morbidity related to surgical reintervention, 
the important enhancement of endoscopic procedures 
and technological innovations introduced in endoscopic 
equipment have made the endoscopic approach a 
minimally-invasive alternative to surgery, and, in many 
cases, a suitable first-line treatment of bariatric surgery 
complications. There is now evidence in the literature 
supporting endoscopic management for some of these 
complications, such as gastrointestinal bleeding, stomal 
and marginal ulcers, stomal stenosis, leaks and fistulas 
or pancreatobiliary disorders. However, endoscopic 
treatment in this setting is not standardized, and there 
is no consensus on its optimal timing. In this article, 
we aim to analyze the secondary complications of the 
most expanded techniques of bariatric surgery with 
special emphasis on those where more solid evidence 
exists in favor of the endoscopic treatment. Based on 
a thorough review of the literature, we evaluated the 
performance and safety of different endoscopic options 
for every type of complication, highlighting the most 
recent innovations and including comparative data with 
surgical alternatives whenever feasible. 
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Core tip: In developed countries obesity is a prevalent 
and rising problem. Bariatric surgery is the most 
effective treatment to obtain sustainable weight loss 
but postoperative complications may be serious and 
challenging to treat. The minimally-invasive character of 
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endoscopic treatment has led endoscopic management 
of bariatric complications to become a suitable alternative 
to surgery. In this article, we discuss the indications of 
endoscopic treatment after bariatric surgery and the 
available endoscopic techniques. 
Souto-Rodríguez R, Alvarez-Sánchez MV. Endoluminal 
solutions to bariatric surgery complications: A review with a 
focus on technical aspects and results. World J Gastrointest 
Endosc 2017; 9(3): 105-126  Available from: URL: http://www.
wjgnet.com/1948-5190/full/v9/i3/105.htm  DOI: http://dx.doi.
org/10.4253/wjge.v9.i3.105
INTRODUCTION
Obesity is a major health problem with significant 
morbidity and mortality. An estimated 3.4 million 
deaths worldwide were caused by obesity in 2010, and 
its prevalence rose by 27.5% for adults between 1980 
and 2013[1]. Due to the far superior results of surgical 
treatment compared with obesity medical therapy, the 
American Society for Metabolic and Bariatric Surgery 
stated a grade A recommendation for bariatric surgery 
for patients with a body mass index (BMI) ≥ 40 kg/
m2 or those with a BMI ≥ 35 kg/m2 and comorbid 
conditions who have failed to respond to prior medical 
intervention[2]. The most frequent bariatric operations 
performed worldwide are Roux-en-Y gastric bypass 
(RYGB) and sleeve gastrectomy (SG) (Figure 1). 
Although Gastric Roux-en-Y bypass (RYGB) is the most 
effective bariatric surgery, it is technically demanding, 
and, therefore, SG has been increasingly performed due 
to its simplicity. Laparoscopic adjustable gastric banding 
(LAGB) is now an outdated procedure despite its safety 
profile because of its poor long-term results. Other 
bariatric techniques, such as biliopancreatic diversion 
with or without duodenal switch (BD/DS) and jejunoileal 
bypass, have been abandoned due to severe metabolic 
complications[3].
Weight-loss surgery has been associated with an 
important reduction in obesity-related medical com-
plications, such as diabetes mellitus and other car-
diovascular risk factors[4]. The increased use of laparos-
copy and improvements of surgical techniques have led 
to a significant decrease in surgical complications with a 
current mortality lower than 1% in centers of excellence. 
However, postoperative complications are still common, 
and minimally invasive endoscopic treatments have 
gained popularity to avoid surgical reinterventions.
In the literature, up to 30% of patients present 
symptoms in the perioperative setting requiring endos-
copic evaluation[5]. The most common symptoms are 
abdominal pain, nausea, vomiting, dysphagia and 
gastrointestinal bleeding. These symptoms are predictive 
of pathologic findings at endoscopy, and, interestingly, 
this predictive potential depends on the time elapsed 
from surgery. In the first 6 mo following surgery, 85% 
of upper endoscopic explorations had, at least, one 
abnormal finding vs 47% after 6 mo. In addition, 
time elapsed from surgery also predicts the type of 
complication; in the first 6 mo after the surgery, the 
incidence of staple-line dehiscence is higher whereas 
stomal ulcerations or strictures are less probable[5]. 
Optimal management should be individualized because 
surgical reconstruction may make endoscopic access 
and resolution difficult or even impossible. In addition to 
these local complications directly related to the surgical 
procedure, other long-term metabolic consequences 
secondary to the rapid loss of weight, such as gallstones 
or hepatobiliary disease, may further complicate the 
clinical scenario and may also require endoscopic 
management[5].
Because the majority of symptomatic patients 
are endoscopically evaluated, the gastroenterologists 
must be familiar with post-surgical anatomy and 
complications, and their endoscopic management. In 
this review, we will briefly describe the most frequent 
complications related to every type of bariatric surgical 
technique and the most recent and remarkable results 
about the endoscopic procedures with proven effective-
ness.
GASTROINTESTINAL BLEEDING
Gastrointestinal (GI) bleeding after bariatric surgery 
can occur in the first 30 d following surgery as an early 
complication, or afterwards as a delayed one. Early 
bleeding usually presents within the first 48 h in 1%-5% 
of patients after RYGB[6]. SG presents a variable rate of 
bleeding between 0% and 8%[7] whereas LAGB is almost 
never complicated with bleeding (0.1%)[8]. The risk of 
iatrogenic perforations at the surgical site along with the 
self-limited character in most cases are the reasons why 
minor bleeding is usually managed conservatively with 
fluid resuscitation or blood transfusion and proton pump 
inhibitors. In cases of severe bleeding, endoscopic ex-
ploration is mandatory, or even surgical intervention 
when no blood exteriorization is observed and after CT 
diagnosis of extraluminal bleeding[9,10]. Late bleeding 
is usually secondary to anastomotic ulceration and is 
almost never extraluminal.
Endoscopy must be performed with minimal insuff-
lation with CO2 if possible. Upper endoscopy is able 
to reach the gastrojejunal anastomosis but a balloon-
assisted enteroscopy may be required to access the 
excluded gastric remnant, which carries a risk of per-
foration due to the immature anastomoses and the 
traction forces during enteroscopy. In this situation, if a 
skilled endoscopist is not available, surgical intervention 
should be the first option. 
After bariatric surgery, the most common bleeding is 
at the staple-line of the anastomotic gastrojejunostomy 
in RYGB but it can occur anywhere in the gastrointestinal 
tract. There are few studies published on this subject but 
endoscopic management of bleeding at the gastrojejunal 
anastomosis has been successfully managed with 
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the standard hemostatic modalities without more 
complications than in contexts other than bariatric 
surgery[11]. Injection of epinephrine or polidocanol[12], 
thermal methods[13] and endoclips have been used with 
success[14]. Nevertheless, mechanical methods, especially 
endoscopic clips, should be favored. Thermal techniques 
must be avoided at the staple-line and the anastomosis 
as for other surgical settings to prevent tissue injury. 
Hemostatic powder might be another option although no 
case has been reported thus far.
STOMAL AND MARGINAL ULCERS
Ulceration is a late complication that typically occurs 1 
to 6 mo after surgery. In patients with epigastric pain 
after RYGB, ulceration at the gastrojejunal anastomosis 
is the most frequent finding during endoscopy and is 
also one of the most common complications after RYGB 
appearing in up to 16% of patients[15]. Other symptoms 
at diagnosis are nausea, vomiting, and bleeding, either 
overt or occult. Ulcerations on the gastric side of the 
anastomosis are referred to as stomal ulcers and those 
on the jejunal side as marginal ulcers[16]. 
The cause of stomal ulcers is known to be ischemia 
whereas the mechanism for marginal ulcers is not well 
understood. Local ischemia, acidic gastric secretions, 
NSAID use, alcohol intake, smoking, or a foreign body, 
such as non-absorbable suture material, have been 
suggested as plausible causes[17]. After resecting the 
duodenum, there is no longer a pH buffering function, 
and acidic secretions are poorly tolerated at the 
jejunum; however, refractory ulcers should raise the 
suspicion of a gastrogastric fistula causing continuous 
acid exposure. The role of Helicobacter pylori (H. pylori) 
is controversial in this setting, and there is no consensus 
regarding preoperative screening for H. pylori and 
subsequent eradication therapy in patients undergoing 
bariatric surgery[18]. However, some authors have 
suggested that H. pylori-related mucosal damage before 
surgery may result in postoperative ulceration even after 
eradication. The efficacy of proton pump inhibitors (PPI) 
in preventing marginal ulcers is controversial[19]. After 
ulcer development, most authors advocate indefinite PPI 
treatment but if aspiration of gastric pouch fluid reveals 
a non-acidic pH, then acid suppression is less effective 
and sucralfate may be the treatment of choice[20].
The endoscopic intervention is especially indicated 
when a foreign body is suspected to be the underlying 
cause. Embedded sutures or staples can promote an 
inflammatory reaction exposed to the irritating lumen 
environment; thus, large amounts of sutures should be 
removed even in asymptomatic patients[21]. A double 
channel endoscope may be useful to introduce grasping 
or rat tooth forceps, loop cutters, endoscopic scissors 
or argon plasma coagulation probes. In some series 
that use these endoscopic accessories to manage 
foreign bodies, over 70% of patients reported clinical 
improvement[22]. Endoscopy should be repeated at 8 
wk to confirm ulcer resolution. In cases of unhealed or 
recurrent ulcers, a gastrogastric fistula or staple-line 
dehiscence should be investigated.
A particular type of ulceration is related to gastric 
band erosion, which occurs in 1%-4% of patients 1 or 
2 years after LAGB[23]. Traditionally, surgical removal 
performing another bariatric surgical reconstruction 
during the same procedure was the classical approach. 
Figure 1  Bariatric surgery procedures. A: Adjustable gastric 
band; B: Roux-en-Y gastric bypass; C: Sleeve gastrectomy; D: 
Sleeve gastrectomy with biliopancreatic diversion. 
A B
C D
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Nevertheless, endoscopic extraction of gastric bands is 
feasible and is especially useful in patients not suitable 
for a new bariatric intervention. The procedure usually 
involves several steps. First, partially migrated bands 
must become more accessible from the gastric cavity 
and this is achieved by placement of a fully covered 
self-expanding metal stent (FCSEMS) inducing mucosal 
necrosis[24,25]. Next, the band must be transected before 
band removal transorally. Although different endoscopic 
procedures have been described to cut the band, such 
as band transection using argon plasma, neodymium-
YAG laser or endoscopic scissors, the easiest method 
is the wire-cutting technique. In this technique, a 
guide-wire is passed through the band and the distal 
end of the wire is caught and pulled back on the other 
extremity forming a loop. Then, the band transection 
is accomplished using a mechanical lithotripter. Before 
band extraction, the subcutaneous port must be dis-
connected. The technical success range from 80% to 
100%, and failures are mainly related to adherences 
between perigastric tissues and the gastric band[25-28]. 
STOMAL STENOSES
Stenoses are usually secondary to stricture development 
although they may be due to a malfunction of prosthetic 
devices. Although LAGB and SG may be complicated 
with stenosis, this complication is more commonly 
observed after RYGB and more often located at the 
gastrojejunal anastomosis. Less frequent locations are 
the jejunojejunal anastomosis and sites of passage 
through the mesocolon or intestinal adhesions. Stomal 
stenosis occurs in as many as 3% to 28% of patients 
who have undergone RYGB[29-32] and are defined as 
stomas that are smaller than 10 mm in diameter or 
as stomas that prevent the passage of the standard 
gastroscope[33]. The clinical presentation consists of 
dysphagia, nausea, vomiting and early satiety without 
abdominal pain. They develop gradually; therefore, 
they are usually late complications presenting several 
weeks after the surgical intervention. Medical factors, 
such as the use of NSAIDs, smoking or alcohol intake, 
can promote stenosis development. Moreover, surgical 
factors, including the method for anastomosis creation 
and mechanical tension or ischemia at the anastomosis, 
are also associated. Anastomoses performed with a 
circular stapler resulted in a higher stricture rate than 
those hand-sewn or performed with a linear stapler[34].
RYGB
The most common endoscopic approach is dilation with 
a through-the-scope balloon (TTS balloon). Although 
the use of fluoroscopy is advisable to avoid entry into 
the blind limb in cases of non-traversable stenosis with 
the gastroscope, balloon dilation without fluoroscopy 
guidance has been reported to be safe. In a series of 
22 patients with a stomal stenosis, balloon dilation was 
performed without fluoroscopy and achieved a success 
rate of 100% without any perforation[35]. Based on 
these results, the authors concluded that fluoroscopy 
is not always required for positioning the balloon and 
recommended the use of fluoroscopy liberally in difficult 
cases.
Balloon dilation to 15 mm in the first session has 
been shown to be safe although several dilations, every 2 
or 3 wk with balloon diameters gradually increased from 
12 to 20 mm, are often needed to achieve resolution 
and to prevent perforation and weight regain secondary 
to the loss of volume restriction[36]. Overall, the most 
recent studies in the literature have reported a success 
rate higher than 90% with very few complications (Table 
1)[35-46]. It is important to note that in one study reporting 
on balloon dilation in 72 gastrojejunal strictures after 
RYGB, late strictures (> 90 d after RYGB) were found to 
have an inferior rate of response to endoscopic dilation 
(61% vs 98%) and often required revisional surgery[46]. 
When balloon dilation has failed to succeed, endoscopic 
incision using a needle knife papillotome prior to balloon 
dilation can be tried[47]. Suture material at the site of 
the stenosis can also hinder full balloon expansion and 
its removal may be necessary before the procedure[48]. 
In addition, some authors have reported satisfactory 
results with injection of a saline solution or steroids in 
the stenosis after balloon dilation. This may prevent 
restenosis by disrupting the scar tissue; however, the 
real efficacy and mechanism of action are not well 
known[40].
The most feared complication is perforation, which 
occurs in 3%-5% of patients after balloon dilation[37]. 
Early detection of this complication is crucial. Perforation 
may be managed by stent insertion or surgical repair. 
In addition to perforation, another risk of dilation is 
weight regain related to the loss of volume restriction. 
Nevertheless, some of the published studies have 
analyzed the impact of dilation on the decrease in 
weight-loss rate. The weight loss at baseline and during 
the follow-up did not differ from that of patients without 
stricture[41].
Savary-Gilliard bougie dilation (Wilson-Cook Medical 
Inc, Winston-Salem, NC) is another method to dilate 
anastomotic strictures. Although few patients with 
post-bariatric stenoses have undergone this technique, 
it seems to be highly effective and safe. Two studies 
have demonstrated a 100% efficacy without serious 
complications[49,50].
Esophageal FCSEMS have also been used to treat 
chronic gastrojejunostomy strictures with a 12.5% 
successful response[51]. In this study, all of the patients 
had a stricture at the gastrojejunal anastomosis after 
RYGB but one had a stricture at the duodeno-ileal 
anastomosis following BPD/DS. The poor response was 
associated with stent migration.
LS
The prevalence of symptomatic stenosis following 
laparoscopic sleeve gastrectomy (LSG) is between 0.1% 
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and 3.9%[52]. In patients with LSG, functional stenosis 
may occur at the angularis incisura or the gastroeso-
phageal junction and endoscopic treatment seems to 
play a smaller role based on the lower efficacy rates. 
In a study of 16 patients who underwent TTS balloon 
dilation under fluoroscopic or endoscopic guidance, the 
efficacy was only 44% after 1 to 3 sessions[53]. Repeated 
sessions of endoscopic dilation should be indicated only 
in patients with some symptomatic relief following the 
first session because these strictures are more likely due 
to a fibrotic reaction. In contrast, endoscopic dilation has 
no efficacy when twisting rotation of the sleeve is the 
cause of functional stenosis and these patients should be 
managed surgically[53,54]. There are some reports on the 
use of 30 mm achalasia balloons to treat SG strictures 
with 71% to 100% resolution rates[52]. These higher 
rates of resolution are overshadowed by the higher risk 
of perforation secondary to the more rigid achalasia 
balloons. 
More recently, new self-expanding metallic stents 
have been manufactured to treat leaks after SG: Megas-
tents (Taewoong Medical Industries, South Korea) and 
Hanaro (MITech, Seoul, South Korea). These stents 
are longer than conventional SEMS positioned from 
the distal esophagus to the duodenal bulb bypassing 
the entire gastric sleeve. Although they are intended 
to reduce the migration rate while sealing a leak after 
SG, they also confer radial strength useful to dilate a 
possible stenosis at the same time[55]. Nevertheless, 
studies using these stents have only reported results of 
leak closure.
LAGB
Mechanisms of stenosis after gastric banding include 
fibrotic reaction, band rotation and adhesions with 
pouch angulation. Dilation is only effective in cases of 
fibrotic stenosis. If endoscopic dilation is not successful 
after one session, another endoscopic session should 
not be performed and surgical options must be consi-
dered including conversion to RYGB[56].
ANASTOMOTIC LEAKS AND FISTULAS
Leaks are defined as the exit of luminal contents 
due to a discontinuity of the tissue apposition at the 
surgical anastomosis, whereas fistulas are abnormal 
passageways usually between two hollow viscera or 
communicating to the skin and they result from chronic 
healing of local inflammation caused by leaks. The 
incidence of staple-line or anastomotic leaks varies 
depending on the type of bariatric surgery, with studies 
reporting 2% to 5% for laparoscopic RYGB, 1.6% to 
2.6% after open RYGB and 0.6% to 7% in patients 
following a sleeve gastrectomy[29,30,57-59]. Because 
LAGB does not involve transection of the stomach, the 
reported incidence of leakage is very low, ranging from 
0% to 0.5%[60-62]. Leaks are the most dreadful compli-
cation and after pulmonary embolism they represent 
the second most common complication leading to death 
after bariatric surgery[63]. Although several patient-











Complication rate (%) Perforation rate 
(%)
  Barba et al[36]   24 28-270 1-3 100 8-13 mm 0 0
  Go et al[37]   38 53.9 (21-168) 1-6   95 12-16 mm 3
1 pneumothorax and pneumomediastinum
3
  Rossi et al[38]   38 - 1-3 100 - 0 0
  Carrodeguas et al[39]   94 52.7 (20-154) 1-4   99 - 2.1
Perforations
  2.1
  Catalano et al[40]   26 63 (28-63) 1-7     96.2 8-15 mm 3.8
Surgical revision for recurrent stenosis
0
  Peifer et al[41]   43 49.7 (24-197) 1-3   93 9-20 mm 0.5
Surgical revision for recurrent stenosis
0




  Ukleja et al[43]   61 60 (30-180 ) 1-5 100 6-18 mm 4.9
3 perforations
   2.21
  Mathew et al[44]   58 66.2 (12-365) 1-7 100 6-20 mm 3.2
Perforations
   3.2
  Da Costa et al[45] 105 90 (30-270) 1-4 100 6-20 mm 3.8
1 hemorrhage
3 perforations
   1.81
  Espinel et al[35]   22 126 (26-768) 1-4 100 12-20 mm 4.5
Small tear
0
  Yimcharoen et al[46]   72 46 < 90 
25 > 90 
1-15      84.7
98% < 90 d
61% > 90 d
8-18 mm 1.3
1 perforation, pneumoperitoneum and death
  1.3
Table 1  Results of series on post-Gastric Roux-en-Y bypass anastomotic stricture balloon dilation
1Perforation rate of the dilations referred to the number of sessions. R: Retrospective; RYGB: Roux-en-Y gastric bypass. 
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related conditions, such as superobesity, age above 
55 years, male sex, and a personal history of diabetes 
mellitus, sleep apnea, hypertension or previous surgery, 
are thought to predispose patients to leaks[64], early 
postoperative leaks within the three first days after 
surgery are usually due to a technical error, such as 
anastomotic tension, stapler malfunction and suture 
or staple-line seepage[65]. However, leaks presenting 
later in the perioperative setting after RYGB are usually 
due to ischemia at the staple-line or anastomosis 
and they appear with decreasing frequency at the 
gastrojejunostomy, gastric pouch and jejunojejunal 
anastomosis[66-68]. High pressure in the gastric sleeve 
due to stenosis at the incisura, pyloric dysfunction and 
twisted or atonic sleeve is the most common cause of 
leaks several days after LGS but ischemia may also 
be responsible following ligation of the short gastric 
arteries. In this setting, most leaks occur at the angle of 
His where the highest pressures are present[69-71]. The 
uncommon cases of leak after LAGB are mainly due to 
ischemia secondary to band slippage or migration[72]. 
However, the rate of leaks is increased after revision 
bariatric procedures for gastric band failures and it has 
been reported to be as high as 18%[73,74]. This occurs 
more often when the revision surgery after LAGB is 
accomplished to treat band complications, such as band 
erosion, slippage and migration, than after a revision 
procedure for weigh regain. Factors contributing to this 
increased risk of leaks are the fibrotic and inflammatory 
tissue surrounding the band and secondary adhesions 
to the neighboring structures like the pancreas[73,74]. 
The incidence of fistulas is not well known although 
some authors have reported that 14% of patients with 
anastomotic leaks will develop fistulas[67]. The most 
common sites are gastrogastric and gastrocutaneous. 
Gastrogastric fistula is a specific complication of RYGB 
consisting of an organized communication between the 
gastric pouch and the gastric remnant. It was one of 
most common complications in the past but currently, 
after generalizing the transection of the stomach, the 
incidence of gastrogastric fistulas has decreased to 
1.2%-6%[75-77].
Clinical presentation of leaks is variable, ranging from 
asymptomatic patients to sepsis-related multiorgan 
failure. Early suspicion of a leak must be raised in cases 
of any deviation from the normal postoperative course 
with tachycardia being the most sensitive indicator 
of a leak[67,78]. Chronic fistulas show more indolent 
presentation. Abdominal discomfort and heartburn 
due to acid flow into the pouch and weight regain are 
the most common symptoms in patients who present 
a gastrogastric fistula. The most sensitive method to 
diagnose leaks is computed tomography with oral, 
water-soluble contrast[79]. Nevertheless, leaks may be 
discovered by routine upper gastrointestinal studies 
performed systematically by some authors during the 
first three days after surgery, or by oral administration 
of methylene blue when drains are still in place[80,81]. 
Endoscopic diagnosis is also feasible, combining a bubble 
test (drain immersion during endoscopic insufflation) 
with the administration of contrast with methylene blue 
into the drain while keeping fluoroscopic and endoscopic 
view looking for a leak[82].
The treatment strategy depends on the clinical 
condition of patients and the time of presentation, 
and relies on the following three mainstays: Medical 
support, drainage of leaked material and repair of the 
wall defect. Therapeutic medical measures involve 
suppression of the oral intake, parenteral nutrition or 
distal enteral feeding, and broad-spectrum intravenous 
antibiotics. For hemodynamically unstable patients 
with generalized peritonitis or sepsis, surgical drainage 
and cleansing of the peritoneal cavity is mandatory 
and a feeding jejunostomy should be performed at 
the same time to allow enteral nutrition. Otherwise, 
conservative management based on medical therapy 
and external drainage is a convenient approach that 
has been reported to achieve leak resolution in 75% 
of early, asymptomatic and small-volume leaks[83]. 
However, some authors prefer surgical repair in these 
early small leaks[84]. In stable patients with larger leaks 
or leaks presenting late in the postoperative course, 
where conservative management keeps the patient 
stable but does not succeed in stopping the leak, further 
treatment should be considered. Nevertheless, primary 
surgical repair is associated with high rates of recurrence 
and other reinterventions, such as gastrectomy, sleeve 
conversion to gastric bypass or fistulojejunostomy, which 
have high morbidity; therefore, the management of 
these patients has shifted from surgery to less invasive 
endoscopic therapy[67,85]. 
Endoscopic treatment is used very often as an 
adjuvant therapy to surgery but the management of 
post-bariatric leaks may be accomplished entirely by 
endoscopic means. The endoscopic approach usually 
involves a stepped and multimodal procedure as has 
been previously described[86]. 
Endoscopic internal drainage 
Before any attempt to close the wall defect, the first 
step is to guarantee the appropriate drainage of the 
leaked content. For early leaks, this is commonly 
accomplished by surgical drains maintained in the post-
operative period but if drains are no longer in place, 
percutaneous drains should be placed either surgically 
or by interventional radiology whenever accessible. 
Nevertheless, in patients with delayed leakage or 
when surgical cleansing is not required or for those 
whose collections are not radiologically accessible, the 
endoscopic internal drainage (EID) into the digestive 
lumen might be the first option for well-circumscribed 
collections[87]. In addition when combined with surgical 
cleansing in patients presenting with severe sepsis, EID 
allows early removal of surgical drainage preventing 
chronic fistula tract formation[88]. EID consists of trans-
fistulary insertion under fluoroscopy guidance of one 
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or two 7 or 8.5 Fr double-pigtail plastic stents, or one 
double-pigtail stent and one nasocystic catheter in cases 
of large collections requiring lavage to eliminate pus 
and debris[87] (Figure 2). Double-pigtail stents keep the 
leak orifice open favoring the passage of fluid content 
into the digestive lumen with progressive reduction in 
the collection size until it eventually becomes a virtual 
cavity. Meanwhile, a foreign body reaction in the edges 
of the leak is triggered by plastic stents promoting 
the reepithelialization over the stent and the fistula 
closure, resulting in an all-in-one procedure without 
the need of further treatment. A residual small cavity 
like a pseudodiverticulum is common at the end of the 
process without any clinical repercussion[88]. In some 
cases, the leak orifice is not clearly identified or the 
communicating tract between the digestive lumen and 
the fluid collection is complex, then, internal drainage 
may be accomplished by EUS-guided drainage, such as 
for pseudocysts or other postsurgical collections[87-90]. In 
addition to stenting, debridement may also be needed 
in cases of infected collections containing necrotic tissue. 
Endoscopic necrosectomy is also feasible, similar to 
treatment of organized pancreatic necrosis[86,90,91].
Although EID is now most commonly used as a first-
line approach, it has also been reported as a bridge to 
other endoscopic methods and as a salvage treatment 
when other endoscopic techniques have failed[87-89]. 
In the largest series reporting on EID, double pigtails 
were delivered as a first line approach in 66 patients[88]. 
Among them, 42 had a surgical drainage placed close to 
the leak. The 78% of patients were cured by EID after 
a mean of 58 d. Oral diet was reassumed following the 
confirmation of collection reduction in a CT performed 
three days after pigtail insertion. In this study a proto-
col with systematic endoscopic review every 4-6 wk 
was followed. At each session stent exchange was 
performed until fistula healing was achieved to avoid 
stent obstruction and to stimulate tissue granulation 
by the traumatism induced by the stent on the fistula 
edges. In a more recent study on 33 patients with 
fluid collections after SG or RYGB (in 19 patients after 
previous unsuccessful endoscopic treatment), internal 
drainage achieved 78.8% clinical success[87]. After 
confirming biological and clinical improvement, this 
approach allowed early oral re-feeding in the first 24-48 
h following stent insertion without any negative impact 
on the final results. No standardized protocol to remove 
the stents was observed and the decision was left to 
the discretion of the endoscopist and decided on an 
individual basis, although the stent retrieval was planned 
at least 4 mo after complete clinical resolution. However, 
in most patients successfully treated by internal 
drainage, no other endoscopic procedures were required 
because stents often migrated spontaneously. In 
addition to the high efficacy, EID is burdened with a low 
complication rate. In the first study 6 stenoses, as well 
as two stenoses in the second series, were observed, 
probably related to granulation tissue induced by the 
A B
C D
Figure 2  Large collections requiring lavage to eliminate pus and debris. A: Early fluid collection after RYGB; B and C: Transfistulary drainage of the fluid 
collection. A 10 Fr double pigtail was placed; D: Nine days after stent placement the collection significantly reduced and became a virtual cavity. Yellow arrow: Double 
pigtail stent; white arrow: Reduced cavity after drainage. RYGB: Roux-en-Y gastric bypass.
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pigtails, and successfully treated either with achalasia 
balloon dilation or FCSEMS[87,88]. In the second study, 
two other complications were also reported[87]. One 
patient presented bleeding from the leak orifice with 
internal stent migration that was endoscopically treated 
by endoscopic coagulation and endoscopic retrieval 
of the migrated stent. The other patient developed a 
splenic hematoma that required surgical treatment. 
The authors argued that the proximity of the pigtails 
to the spleen parenchyma might explain this serious 
complication. Despite the high efficacy of EID, some 
patients in both studies did not respond to EID after 
median stent dwell duration of 58 d (range 10-206) and 
115 d (range 23-773) respectively, and other treatments 
were required. The appropriate time interval for stent 
exchanging and the optimal timing to consider EID 
failure in leak healing and to proceed with other surgical 
or endoscopic treatments remain to be defined. 
Methods other than pigtail stenting for internal 
drainage have been described. To drain the leaked 
content, stricturotomy, more recently named as septo-
tomy, has been successfully tried in patients with post-
operative leaks after SG or DS[92,93]. This procedure 
derives from the endoscopic treatment for Zencker 
diverticulum and involves cutting the septum between 
the perigastric cavity and the gastric pouch using argon 
plasma coagulation or a needle-knife. In a prospective 
study, 27 patients were treated with stricturotomy and 
after 1 to 6 endoscopic sessions, all of the patients had 
their fistulas closed. More than half of the patients in this 
study presented stenosis at the angularis incisura, and 
they were all endoscopically dilated. This result highlights 
that besides drainage it is of paramount importance to 
detect and treat predisposing factors that can perpetuate 
the leak. Therefore, in combination with achalasia 
balloon dilation of post-LSG stenosis, septotomy has 
become an appealing alternative to treat chronic leaks 
connected to a not drained cavity after LSG. This pro-
cedure allows decreasing intragastric pressure, rerouting 
the gastric content and the internal drainage of the 
cavity by cutting the staple-line interposed between the 
cavity and the gastric lumen[92,93]. Anecdotal experience 
with internal drainage using a vacuum-assisted closure 
system is now available[94,95]. This device consists of 
a sponge endoscopically placed inside the cavity and 
connected by a transnasal tube to external continuous 
vacuum suction[96]. The sponge must be changed every 
2-4 d and adapted as the fistula cavity reduces in size 
until it eventually seals. The sponge results in granulation 
tissue and the vacuum helps to extract the fluid content, 
improves blood flow and promotes leak closure. Nine 
patients in the post-bariatric surgery context have been 
treated with this device recently. The rescue rate was 
89% after an average of 50 d and 10.3 procedures per 
patient. One patient required surgery and in two others, 
a complementary over-the-scope clip was placed[95]. 
Endoscopic treatment of wall defects
Some patients have their leaks closed after conservative 
management or internal drainage but in other cases 
the leak persists. For these patients and for those with 
larger leaks at presentation who will predictably fail to 
respond to the above measures, further intervention 
is required. Therefore, once drainage is ensured, the 
next step is aimed at treating the wall defect. There 
are two different endoscopic strategies to proceed, 
either to primarily close the leak orifice or to exclude it 
by diverting the enteric content, and the choice mostly 
depends on the size of the wall defect. Both strategies 
may be complementary usually in a sequential manner 
or an adjuvant therapy to surgical drainage.
Wall defect exclusion: The endoscopic technique to 
divert the gastrointestinal stream is stent placement. 
Endoscopically placed self-expandable endoscopic stents 
(SEES) offer several advantages. They decrease the 
intraluminal pressure, which is one of the pathophy-
siologic factors of leaks after SG, prevent or decrease 
peritoneal contamination by excluding the wall defect 
from esophagogastric secretions and thus, promote 
healing of the leak and permit oral nutrition to be 
resumed[51,97]. This is the endoscopic treatment for 
leaks after bariatric surgery where most evidence 
is available. Table 2 shows the largest studies in the 
literature reporting on stent treatment of leaks after 
bariatric surgery[98-111]. In one meta-analysis on 7 
studies published in 2011, fistula closure was achieved 
in 88%. The rate of successful removal of the stent after 
leak closure was 92% and stent migration, noted in 
17% of cases, was the most common complication[64]. 
However, the largest studies have been published after 
this meta-analysis and the rates of leak closure and 
complications range from 65% to 100% and 14% 
to 86%, respectively, with migration being the most 
frequent complication with rates of 5%-67%[98-111]. It is 
noteworthy that figures of success in most studies have 
included not only primary success following stenting 
but also success after combining stenting with other 
complementary endoscopic techniques. Moreover, these 
studies have pooled patients with different bariatric 
surgeries, mostly RYGB and SG. Additionally, the timing 
of stenting after surgery is heterogeneous, the size of 
the wall defect has rarely been reported and different 
stents have been used. All of these issues are important 
factors influencing rates of success and migration. Due 
to anatomical reasons, lower rates of leak closure are 
achieved in SG because the area to cover is larger, it 
is more difficult to obtain close apposition between 
the stent and the wall defect and tissue hyperplasia 
increasing the water tightness is less common[99]. It has 
also been advised that management of postbariatric 
surgery leaks must be guided by the size of the wall 
defect as it has been shown that leaks larger than 1 cm 
take longer to heal after stenting or even fail to seal with 
only stent placement[112]. In addition, the time interval 
between leak development and endoscopic stenting 
is a proven factor that impacts outcomes. The fibrotic 
transformation of leaks into chronic fistulas over time 
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  Salinas et al[98] 17 RYGB 1-3 wk PCSEMS 94 41%
1 migration, 2 mucosal 
tears,
4 stent obstruction by food
  6 1.2 (1-2) 3.2 ± 1.2 mo





1 migration, 2 dysphagia 
due to tissue hyperplasia
  5 1-6 NA












  Blackmon et al[101] 10 RYGB/LGS NA FCSEMS/
PCSEMS
100 NA NA NA NA
  Leenders et al[102] 11 RYGB/LSG 8 d
(1-33)
FCSEMS 73 50%
3 disintegrated stent, 2 
migration
17 2 (1-4) 16 wk (5-63)





1 mucosal stripping, 1 
perforation,
1 dysphagia, 1 stricture, 1 
bleeding
1 stent angulation, 7 
migration
15 NA 44 d (3-90)
  Orive-Calzada et al[104] 11 LSG NA FCSEMS 73 NA NA NA NA
  Alazmi et al[105] 17 LSG < 1 wk (10)
1 wk-1 mo 
(6)
> 1 mo (1)
PCSEMS 76 36%
2 bleeding, 3 dysphagia, 1 
migration
  6 NA 42 d (28-84)
  Quezada et al[106] 29 RYGB/SG 8 d
(0-104) 
CSEMS 96.5 41%
10 migration, 1 stent 
fracture,
1 opening of blind end of 
alimentary limb
34 NA 82 d (2-352)
  Murino et al[107] 91 RYGB/LSG 25 d
(2-308)
PCSEMS 81 22%
5 bleeding, 2 perforation (1 
death),
7 migration, 13 esophageal 
stricture
  8 1 (1-7) NA
  Fishman et al[108] 26 LSG < 1 wk (1)
1-6 wk (17)
7-12 wk (5)
> 12 wk (3)
FCSEMS2 65 46%
4 severe stent intolerance 
(stent removal)
1 severe bleeding, 7 
migration
27 NA NA
  Southwell et al[109] 21 LSG < 1 wk (6)
1-6 wk (12)
7-12 wk (1)




10 migration,, 2 esophageal 
strictures
1 leak due to erosion by the 
stent
5 severe intolerance (stent 
removal)
48 5 (2-13) 75 d (9-187)
  Van Wezenbeek et al[110] 12 RYGB/LSG 8 d (0-24) FCSEMS2 75 75%
7 migration, 1 perforation
1 perforation secondary to 
migration
67 2.4 (1-3) 38 d (28-49)
  Shehab et al[111] 22 RYGB/LSG 11 d
(3-30)
FCSEMS2 82 41%
1 perforation, 1 esophageal 
stricture,
4 migrations, 2 bleeding (1 
death), 1 stent intolerance 
(removal)
18 2.8 (2-5) 6.8 wk (2-14)
Table 2  Results of endoscopic stenting in anastomotic and staple-line leaks after bariatric surgery
1Including migration. Dysphagia and intolerance were included when required endoscopic dilation and/or stent removal; 2Sleeve customized stents. R: 
Retrospective; RYGB: Roux-en-Y gastric bypass; LSG: Laparoscopic sleeve gastrectomy; DS: Duodenal switch; FCSEMS: Fully-covered self-expandable 
metal stent; PCSEMS: Partially-covered self-expanding metal stent; CSEMS: Covered self-expandable metal stent.
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significantly decreases the probability of leak closure 
after stent placement[51,105,107]. Heterogeneity regarding 
all of these clinical factors may explain, at least in part, 
the large differences in rates of success across the 
studies.
SEES, along with sepsis treatment, have become 
an attractive alternative due to the high rates of leak 
closure, its minimally invasive placement, the early 
restoration of oral nutrition and faster recovery with 
shorter hospital stays. Although there is no consensus 
on the optimal timing of stenting, most experts suggest 
early application after diagnosis[113]. In general, stents 
are well tolerated. Minor symptoms, such as nausea, 
vomiting and abdominal discomfort, are common and 
usually transient, but severe stent intolerance has been 
reported, leading to early stent removal. The main 
drawback of SEES is the high rate of migration. Other 
than migration, most complications are conservatively 
managed and not severe; however, severe bleeding 
and perforations have been observed. They are serious 
complications that have resulted in death in a few 
cases and in many occasions are associated with stent 
migration[107,111]. One explanation for the high migration 
rate is that SEES have been designed to treat benign 
and malignant esophageal strictures. In the esophagus, 
close contact between the stent and the mucosa is 
feasible whereas in a gastric pouch the friction between 
the stent and the mucosa is not enough to keep the 
stent in place, predisposing the stent to migrate. This is 
especially true for stents placed across the gastrojejunal 
anastomosis in RYGB[100]. Many attempts to decrease 
the risk of migration and its consequences have been 
made concerning the type and design of SEES and 
different methods to anchor the stents. SEES are 
currently made either of metal (SEMS) or polyester 
(SEPS). Metal stents are said to have a higher friction 
coefficient but, in practice, migration rates seem to be 
similar; however, metal stents are easier to insert due 
to the small caliber and higher flexibility of the delivery 
system[100]. There are two types of metal stents used 
in post-bariatric complications, partially (PCSEMS) and 
fully covered SEES (FCSEMS), and there is controversy 
about which is the better option. The silicon coating 
completely covering the FCSEMS is intended to easily 
remove the stent but this advantage is overshadowed 
by the higher trend toward migration. In contrast, the 
uncovered ends of PCSEMS induce tissue hyperplasia 
that helps to hold the stent in place and increase the 
water tightness of the stent, favoring leak closure. 
Nevertheless, tissue ingrowth into the stent makes stent 
removal difficult and increases the risk of bleeding, 
mucosal stripping and perforation. In the absence of 
randomized prospective trials comparing both stents, 
the choice relies on the preferences of the endoscopist. 
To prevent migration, an increasingly expanded practice 
at present is to use PCSEMS and if significant tissue in 
growth occurs a second SEPS is inserted to pressure 
necrosis of the hyperplastic tissue; then, both stents 
can be safely removed after several days[107]. Ablation of 
the hyperplastic tissue using argon plasma coagulation 
is another option and also, anatomic constrictions can 
improve stent fixation by using overlapping stents (one 
through another) bridging the esophageal junction and 
the pylorus.
The following two FCSEMS have been recently 
designed to be adapted to the sleeve anatomy: ECBB 
Hanarostent® (MI-tech, Seoul, South Korea) (Figure 3) 
and Megastent® (Taewoong, Seoul, South Korea). They 
have a larger diameter to ensure optimal adherence 
to the sleeve wall and are longer, up to 24 cm, to allow 
the proximal end to be placed in the distal esophagus 
and the distal end in the duodenal bulb to decrease 
migration. Whether these stents reduce the rate of 
migration is not clear because few cases have been 
reported and migration has been observed in 18% to 
67%[108-111]. However, one highlighted advantage is 
that these stents are always retrievable endoscopically 
because their larger sizes prevent them to migrate far 
distally in contrast with conventional stents[111]. Two 
problems have been observed with these stents. The 
first one is the worse tolerability to the stent requiring 
stent removal in some cases, with common pain, 
Figure 3  Hanarostent® (MI-tech, Seoul, South Korea). Fully-covered self-
expandable stent adapted to the sleeve gastrectomy anatomy.
Figure 4  Over-the-scope clip (Ovesco Endoscopy, Tübingen, Germay). 
The over-the-scope clip attached to the gastroscope tip and ready to be placed 
on the wall defect. At the bottom of the figure, different available sizes of over-
the-scope clip in the final position once they have been released.
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heartburn and vomiting due to biliary reflux, and the 
second problem is the decubitus lesion in the duodenal 
bulb caused by the distal edge[108,114]. Another type of 
stent is uncovered biodegradable stents. They tend to 
migrate less than FCSEMS and do not need extraction. 
However, the severity of tissue hyperplasia and the time 
to complete degradation cannot currently be accurately 
predicted[115]. Therefore, degradation before the leak 
closure is possible. Anecdotal experience with biode-
gradable stents has been published in three cases with 
satisfactory results[116].
A further attempt to prevent stent migration is endos-
copic stent fixation. Through-the-endoscope clips are 
of limited value[86,117,118] and limited experience with the 
new endoscopic suturing devices to anchor the stents 
shows variable results[119,120].
Despite the above efforts, stent migration is an 
unsolved problem and the longer stents remain in place, 
the higher the probability of migration. For this reason, 
most experts recommend removing the stent after 6-8 
wk, enough time to allow the leak closure and to avoid 
developing excessive tissue hyperplasia. Until then, 
weekly scheduled re-evaluations are highly advised 
because detection of incipient stent dislodgement may 
allow easy endoscopic stent repositioning or removal. 
In cases of stent dislodgement or persistent leakage 
at scheduled controls, additional SEES can be placed, 
covering the proximal and distal ends, to obtain better 
anchoring and to seal the leak. In fact, repeated 
endoscopic procedures are often necessary ranging 
from 1 to 7 in reported studies[98-111].
Endoscopic closure of wall defects: Several 
techniques are available to try directly closing leaks 
instead of covering the leak opening, such as clipping, 
endoscopic suturing, or obstructing the fistula with 
fibrin sealants or plugs. Limited data about the use of 
through-the-scope clips in this indication fail to show 
any advantage of these clips in post-bariatric leaks. 
Preliminary experience with a new clipping device made 
of nitinol and loaded at the tip of the endoscope, over-
the-scope clip (OTSC) (Ovesco Endoscopy, Tübingen, 
Germany) seems promising (Figure 4)[111,121-123]. This clip 
allows full thickness apposition in wall defects smaller 
than 3 cm. The OTSC in post-bariatric leaks has been 
used almost exclusively in SG leaks. Before placing 
the OTSC, appropriate drainage of leaked material is 
required as for SEES and it is strongly advised to de-
epithelialize the fistula edges either with a cytology 
brush or with argon plasma coagulation to promote 
granulation tissue. In two studies reporting on 18 and 
26 patients with SG leaks, leak closure was possible in 
81% and 89%[122,123]. However, several patients in both 
studies also received a SEMS, resulting in 61% and 
62% of primary success. In one of these studies, most 
failures occurred in leaks at the level of the antrum, 
which are well known difficult-to-treat fistulas. The 
procedure was safe without serious complications; only 
one patient developed one gastric stricture caused by 
the OTSC, which was successfully treated with a colonic 
SEMS and one tearing of the fistula edges occurred in 
another patient during the procedure[122]. Nevertheless, 
several endoscopic sessions may be needed ranging 
A B
C D
Figure 5  Upper gastrointestinal series displaying a small gastrogastric fístula ten days after Roux-en-Y gastric bypass (arrows).
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from 2 to 7 in one study and failures to correctly place 
the OTSC may be challenging[123].
The endoscopic injection of two sealant materials, 
fibrin glue and cyanoacrylate, has been used to occlude 
the leak orifice. The mechanism of action of fibrin glue 
is two-fold as follows: Mechanical occlusion by rapid 
formation of a clot and promotion of wound healing 
by inducing fibroblast proliferation. Cyanocrilate is a 
synthetic glue that rapidly solidifies when in contact 
with weak bases, forming a cast[124]. Some cases have 
reported using glue injection as the sole therapy to 
occlude post-bariatric leaks, and frequently multiple 
applications were needed[125-128]. Because these fistulas 
were occluded early in the postoperative course where 
the simple watchful waiting strategy could have been 
enough, the efficacy of glue sealants as the primary 
treatment has been questioned[121]. More often, this 
modality of treatment has been used as an adjunct 
to SEES (Figures 5 and 6). Accordingly, in one study 
reporting on percutaneous treatment of gastrocutaneous 
fistula after LSG in 10 patients, glue injection was 
only effective when performed after endoscopic stent 
placement[129]. 
For refractory gastrocutaneous fistulas after bariatric 
surgery, successful treatment using a biomaterial 
plug has also been described. First developed to treat 
anorectal fistulas, cone-shaped plugs manufactured 
with Surgisis, an acellular matrix extracted from the 
porcine small intestine submucosa, have been used 
to heal postsurgical fistulas in different contexts[130,131]. 
For gastrocutaneous fistulas, these plugs are inserted 
through the cutaneous orifice up to the gastric lumen by 
a rendezvous procedure via endoscopic and percutaneous 
approaches. Before inserting the plug, the fistulous 
tract is abraded using a modified pusher provided with 
multiple barbs over a guide wire. The Surgisis material 
stimulates the proliferation of fibroblasts in the wound 
area without triggering a foreign body response. Two 
studies have presented the results with fistula plugs 
in patients with post-bariatric gastrocutaneous fistulas 
refractory either to at least 4 wk of conservative 
management or to previous endoscopic or surgical 
treatments[132,133]. In both studies, fistula closure was 
achieved in 80% without complications using plugs as 
the sole endoscopic treatment or as an adjunct to SEMS. 
Finally, the use of novel endoscopic suturing sys-
tems in post-bariatric leaks is still experimental. The 
StomaphyX™ system (EndoGastric Solutions, Inc., 
Redmond, WA, United States) and the OverStitch 
system (Apollo Endosurgery, Austin, Texas, United 
States) were reported to be successfully used in two 
bariatric fistulas each[134,135]. Initial experience with the 
EndoCinch system (CR Bard, Murray Hill, NJ) showed 
success but not long-lasting efficacy to close gastrogas-
tric fistulas following RYGB. Among 95 fistulas, 90 
closed after suturing but reopening was observed in 
65% secondary to absorbable sutures after an average 
of 177 d[136]. 
As described above, the management of post-
bariatric leaks is challenging and requires a multidisci-
plinary approach. Frequently, endoscopic treatment is 
an adjunct to surgery although a complete endoscopic 
approach is also feasible[86]. In both cases, endoscopic 
treatment involves not only repeated endoscopic 
procedures but also a combination of different endos-
copic modalities of treatment. As a result, there is 
an important heterogeneity in the management of 
these patients through the literature and the individual 
evaluation of each endoscopic modality is very difficult. 
Accordingly, one recent study has evaluated the 
overall efficacy of interventional endoscopy in this 
setting involving different techniques[137]. Among 110 
included patients with post-LSG leaks, 74% healed with 
endoscopic treatment. In chronic fistulas after 6 mo of 
management, the success rate decreased to 52.4%. The 
most common endoscopic techniques were stenting, 
clip placement and glue application. A mean of 4.7 
endoscopic procedures and 2.5 endoscopic techniques 
per patient were needed. The key role of endoscopic 
treatment relied on stenting, and morbidity in this study 
was also related to stent placement, mainly migration, 
impaction and ulceration, digestive perforation and 
A B
Figure 6  Leak resolution after stent deployement. A: The same gastrogastric fistula (arrow) as in Figure 5 confirmed by CT scan with oral water-soluble contrast. A 
fully covered self-expandable metal stent was inserted. The stent was removed after forty three days and a complimentary injection of fibrin glue was performed; B: A 
new CT scan revelaed the fistula closure. CT: Computed tomography.
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incarceration secondary to tissue hyperplasia. In the 
multivariate analysis, the authors found the following 
four predictive factors of healing following endoscopic 
treatment: The time interval between LSG and fistula 
diagnosis < 3 d, time interval between fistula diagnosis 
and first endoscopy < 21 d, no history of gastric banding 
and a small fistula. 
In the last years, EID with double pigtail stents is 
gaining popularity as a first line endoscopic treatment 
for early and intermediate leaks after bariatric 
surgery[87,88]. The abovementioned shortcomings of 
SEMS have led some experts to carefully reevaluate 
their place in the treatment of post-bariatric leaks 
and to consider EID as an attractive alternative with 
fewer complications and similar success rate[88]. In 
chronic fistulas the endoscopic treatment should be 
always offered before considering radical surgery. 
However, the results of endoluminal therapy, including 
SEMS, in chronic leaks after bariatric surgery are far 
from optimal[51]. Recently, promising results with the 
septotomy procedure in the management of chronic 
leaks connected to a not drained cavity have led some 
experts to favor this technique against SEMS[92,93]. Yet, 
endoscopic treatment in the field of post-bariatric leaks 
has not been standardized and there is no consensus 
about the optimal timing and combination of endoscopic 
procedures. For this purpose, prospective randomized 
studies are eagerly awaited. Until then, and based on 
available evidence at present, we propose an algorithm 
of treatment for leaks after bariatric surgery (Figure 7).
CHOLEDOCOLITHIASIS
Physiologic changes, such as hypersaturation of bile with 
cholesterol secondary to rapid weight loss as it occurs 
after bariatric surgery, induce a lithogenic state[138,139]. 
Clinical suspicion of leak
Abdominal CT with oral water-soluble contrast or upper gastrointestinal series
Peritonitis and/or sepsis Stable patient
Surgical intervention:
Lavage and drainage 
± surgical closure
Early leak Intermediate and late leaks
Not surgical closure or 
persistent leak











Surgical teatment:  
Gastrectomy, 
sleeve conversion 
to gastric bypass or 
fistulojejunostomy
 No resolution







Large leak Small leak
Figure 7  Management algorithm for post-bariatric surgery leaks. Leaks have been classified based on the time period they appear as early, between first and 
fourth day post-operative, intermediate, between the fifth and ninth day after surgery, and late appearing after day ten. aSome authors prefer surgical repair in early 
small-volume leaks; bExcept in uncomplicated small early leaks where conservative treatment has 75% of success in leak closure and the potential benefits of SEES 
are shadowed by the risk of migration and related complications. SEMS: Self-expanding metal stent; OTSC: Over-the-scope clip.
a
b
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Further complicating the scenario, cholecystectomy 
is not systematically performed during laparoscopic 
techniques of bariatric surgery. The decreased gall-
bladder emptying after RYGB also contributes to 
gallstone formation[140,141]. Subsequently, cholelithiasis 
is diagnosed in up to 50% of patients following RYGB 
and therefore, complications secondary to gallstones, 
such as choledocolithiasis, are common[141]. Whereas 
performing endoscopic retrograde cholangiography 
(ERCP) in patients with LAGB or SG is straightforward 
because conventional transoral ERCP is feasible, this 
is not the case for RYGB. Accessing the biliary tree 
after RYGB is challenging and involves crossing the 
gastrojejunostomy, going down the Roux limb to arrive 
at the jejunojejunal anastomosis and up through the 
biliopancreatic limb to reach the papilla. The long 
length of the small bowel that the endoscope must 
traverse and the sharp angulation at the jejunojejunal 
anastomosis are the main constraints that render ERCP 
in patients with RYGB very difficult, even impossible[142]. 
In the attempt to overcome these limitations, alter-
native routes have been proposed (Figure 8). The most 
important one is laparoscopy-assisted ERCP. After the 
first laparoscopic gastrostomy was created intentionally 
to perform ERCP in 2002, experience in the procedure 
has accumulated and it is now a widely accepted 
technique to perform ERCP in postbariatric RYGB (Table 
3)[143-154].
During LA-ERCP, the standard laparoscopy is per-
formed and once the pneumoperitoneum has been 
established, a gastrostomy is created on the greater 
curve of the excluded stomach. Then, a 15-mm trocar 
is placed into the gastrostomy through the abdominal 
wall at the upper left quadrant. A conventional duodeno-
scope is finally passed through the trocar into the gastric 
remnant and progressed through the pylorus into the 
duodenum. A review of the literature yields a rate of 
successful ERCP of 80% to 100% although most studies 
reported a 100% success rate. Complications related to 
the laparoscopic transgastric access were observed in 
0% to 17% of cases. The length of the entire procedure 
was variable and reported operative times ranged 
from 41 to 245 min. However, the ERCP time was not 
  Ref. No. 
ERCP1
Success of CBD 
cannulation (%)




Complications related to 
laparoscopic transgastric 
access
  Ceppa et al[144]   5 80 (4/5) 2 BDS/2 CBD stones/1 CBD sludge NA None None 
  Patel et al[145]   6 100 4 BPS/1 CBD stones/1 normal NA None None
  Roberts et al[146]   5 100 2 BPS/2 SOD/1 CBD stone 64-93 None None
  Gutierrez et al[147] 23 100 3 CBC stone/1 PC/2 N/9 SOD/5 BPS/1 
cholecystitis/1 BPS + SOD/1BSP+ PS
200 (98-138) 1 postERCP 
pancreatitis
17%
2 leak after g-tube 
removal/1 converted to 
open/1 gastrostomy site 
infection




  Bertin et al[149] 22 100 (20/20)2 18 SOD/4 Recurrent pancreatitis 226 1 retroperitoneal 
perforation
5%
1 hematoma of the 
abdominal wall
  Richardson et al[150] 11 100 7 CBD stone/2 BPS/1 SOD/1 CP NA None None
  Saleem et al[151] 15 100 5 BPS/2 CBD stone/3 CBD sludge/1 
PD/1 SOD/1 BPS + SOD/1 BPS + CBD 
stenosis/1 biliary leak
NA None None




  Falcão et al[153] 23 100 17 CBD stone/6 BPS
17 CBD stone/1 CBD sludge/1 BSP
93 1 postERCP 
pancreatitis
None
  Snauwaert et al[154] 23 100 1 N/1 CBD transection NA None 9%
2 converted to open
Table 3  Results of laparoscopy-assisted trans gastric endoscopic retrograde cholangiography in Roux-en-Y gastric bypass
1After excluding laparoscopic trangastric access for gastroduodenoscopy and programmed open procedures; 2Two patients underwent minor papilla 
cannulation. R: Retrospective; ERCP: Endoscopic retrograde cholangiopancreatography; CBD: Common bile duct; BPS: Benign papillary stenosis; SOD: 
Sphincter of Oddi dysfunction; PC: Pancreatic cancer; CP: Chronic pancreatitis; PD: Pancreas divisum; BDS: Bile duct stones.
A B
Figure 8  Endoscopic retrograde cholangiopancreatography approaches 
in Roux-en-Y gastric bypass. A: Laparoscopic-assisted endoscopic retrograde 
cholangiopancreatography; B: Endoscopically-assisted endoscopic retrograde 
cholangiopancreatography.
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reported in the majority of studies and in many cases, 
the surgical procedure included cholecystectomy and/or 
closure of internal hernias found during laparoscopic 
exploration. 
Technological advances in endoscopy have made 
access of the biliary tree in the conventional transoral 
route feasible. Endoscopically-assisted ERCP options 
include double or single balloon assisted ERCP (BEA-
ERCP), spiral overtube-assisted ERCP, percutaneous 
transgastric ERCP and endoscopic ultrasound-directed 
transgastric ERCP. Double and single balloon entero-
scopes, initially conceived for deeper access to the 
small bowel, are useful for performing ERCP in patients 
with complex postsurgical anatomy with similar 
success rates[155-157]. Several studies have evaluated 
the performance of both enteroscopes in ERCP in 
patients with Roux-en-Y anatomy. Reaching the blind 
end was possible in 69%-100% of patients and in 
these cases ERCP was satisfactorily accomplished in 
78%-100%[152,157-166].
However, the majority of patients in these had a 
non-bariatric RYGB where the Roux limb is usually 
shorter. One study directly compared the performance 
of LA-ERCP and BEA-ERCP[152]. In this study, a total of 
32 patients with bariatric RYGB underwent BEA-ERCP, 
either with a single or double balloon, and 24 underwent 
LA-ERCP. Identification of papilla was possible in 72% 
and cannulation and therapeutic success was achieved 
in 59% of patients. The impossibility of reaching the 
papilla was responsible for the majority of failures; 
in fact, a limb length (length of the Roux limb plus 
distance from the Treitz ligament to the jejunojejunal 
anastomosis) less than 150 cm was the only factor 
significantly associated with therapeutic success. One 
case of mild pancreatitis was the only complication 
observed in this study. Nevertheless, LA-ERCP was 
found to be superior with rates of papilla identification, 
cannulation and therapeutic success of 100% each (P 
= 0.005, P < 0.001, P < 0.001, respectively) without 
more complications (one mild pancreatitis and one 
enterocutaneous fistula). Although the mean procedure 
time was shorter in the BEA-ERCP group (106 min vs 
172 min, P < 0.001), the endoscopic time was longer 
(106 min vs 75 min, P = 0.006) reflecting the higher 
complexity of the endoscopic procedure with BEA-ERCP. 
One reason why BEA-ERCP compares poorly with LA-
ERCP is the specific challenges that BEA-ERCP with 
forward view endoscopes must face. In addition to the 
long length of the small bowel that must be traversed, 
it is more difficult to obtain a frontal view of the papilla 
making the cannulation of a native papilla difficult. Once 
the papilla is cannulated, the lack of an elevator and 
the long working channel with limited diameter render 
therapeutic procedures challenging. Most conventional 
accessories used in ERCP are shorter than the entero-
scope working channel. Although this has been over-
come with new short-type enteroscopes with 152 cm 
length (Fujifilm, Osaka, Japan), the diameter is still 
limited to allow the insertion of certain devices.
Spiral enteroscopy is a deep enteroscopy technique 
that uses an overtube with a spiral at the distal end 
(Endo-Ease Discovery SB overtube, Spirus Medical, 
Stoughton, MA, United States). While clockwise rotation 
is applied to the overtube, the spiral transforms the 
rotational energy into linear force to fold the small bowel 
on the endoscope allowing for enteroscope advance-
ment[167,168]. Although few series have reported on spiral 
overtube-assisted ERCP, this technique seems to perform 
similarly to double or single balloon-assisted ERCP but 
no specific data are available in patients with bariatric 
RYGB[157,169-175].
Another route to try ERCP in RYGB is through a 
gastrostomy approach. In two different studies, 28 
and 44 patients respectively underwent ERCP through 
laparoscopic or open surgical gastrostomy at the 
gastric remnant[147,171]. In the first study, the ERCP 
was performed on the same day of the gastrostomy 
procedure after tacking the stomach to the abdominal 
wall, whereas in the second study, ERCP was deferred 
4-6 wk to allow for gastrostomy tract maturity. After 
completing ERCP on the same day of gastrostomy 
creation, a gastrostomy tube was placed to allow for 
tract maturation before its removal no sooner than 4 
wk. In cases of a mature tract, the gastrostomy tube 
was either completely removed or replaced when further 
ERCP procedures were thought to be needed. In these 
two studies, ERCP was successful in 100% and 97% of 
patients, and complications were observed in 18 and 
14.5%, respectively. Most complications were related 
to the gastrostomy. When compared with BEA-ERCP, 
ERCP via gastrostomy was more successful but its 
morbidity was also significantly higher[171]. Percutaneous-
assisted transprosthetic endoscopy therapy is a new 
technique that allows for single-session ERCP via retro-
grade percutaneous endoscopic gastrostomy[172,173]. 
Gastrostomy is created by using a single or double 
balloon enteroscope to access the excluded stomach, 
followed by placement of a fully-covered self-expandable 
metal stent. Conventional ERCP is then performed with a 
standard side-viewing endoscope through the previously 
dilated stent. Another alternative is the endoscopic 
ultrasound directed transgastric ERCP (EDGE)[174]. This 
technique uses endoscopic ultrasound guidance to 
perform the gastrostomy, identifying the gastric remnant 
from the gastric pouch. One week later, transgastric 
ERCP is performed after dilatation of the gastrostomy 
tract. To avoid a two stage procedure, a variation of the 
last technique (internal EDGE) consists of performing 
a EUS-guided gastrogastric fistula[175]. Then, a fully-
covered tissue apposition stent is placed to keep the 
fistula open and to avoid leakage. The stent is dilated 
and a conventional duodenoscope is passed through the 
stent into the gastric remnant and ERCP is performed 
in an anterograde fashion. All of these innovative 
techniques have shown promising outcomes in some 
patients and are appealing due to their minimally 
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invasive character. However, experience is still very 
limited.
Despite having several options for accessing the 
biliary tree in patients with RYGB instead of conventional 
ERCP, either surgically or endoscopically assisted, if 
cholecystectomy has not been performed previously, 
LA-ERCP at the time of laparoscopic cholecystectomy 
seems to be the most suitable approach. Otherwise, 
attempting enteroscopy-assisted ERCP (EA-ERCP) first, 
either with a balloon enteroscope or a spiral overtube, 
seems reasonable because these techniques are less 
invasive. In cases of EA-ERCP failure, continuing with 
LA-ERCP is a cost-saving strategy[152]. There is less 
experience with other techniques although placing a 
gastrostomy tube may be practical when repeated ERCP 
procedures are expected.
CONCLUSION
As obesity becomes more prevalent, weight loss 
treatment, particularly bariatric surgery, is becoming 
a more established therapy. Some complications 
of bariatric surgery, such as leaks, are severe and 
potentially fatal and their treatment is challenging. 
Technological enhancements in endoscopy have led to 
endoscopic management of post-bariatric complications 
gaining popularity, either as a first-line treatment or 
as complementary therapy to surgery. In some cases, 
several endoscopic modalities are available, and, 
although reported results are promising, evidence in 
the literature is often weak and is almost entirely from 
retrospective and small case series. There is a need for 
standardization and guidelines to assist physicians to 
address these complications. For this purpose, larger 
and prospective trials are needed to clearly define the 
place and optimal timing of endoscopic treatment and 
determine whether one endoscopic option is superior to 
surgery or other endoscopic modalities. 
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